|
FAM83E expression based on
|
KIRC : Kidney renal clear cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.996700E-04 |
|
KIRC : Kidney renal clear cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.160990E-03 |
| Normal-vs-Stage2 |
1.601400E-03 |
| Normal-vs-Stage3 |
6.233100E-04 |
| Normal-vs-Stage4 |
1.794200E-04 |
| Stage1-vs-Stage2 |
7.714400E-01 |
| Stage1-vs-Stage3 |
6.060000E-01 |
| Stage1-vs-Stage4 |
1.064210E-01 |
| Stage2-vs-Stage3 |
9.756800E-01 |
| Stage2-vs-Stage4 |
6.128200E-01 |
| Stage3-vs-Stage4 |
3.929200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.577100E-04 |
| Normal-vs-AfricanAmerican |
2.712200E-01 |
| Normal-vs-Asian |
1.070410E-01 |
| Caucasian-vs-AfricanAmerican |
1.149400E-01 |
| Caucasian-vs-Asian |
3.949800E-01 |
| AfricanAmerican-vs-Asian |
6.041800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.959700E-04 |
| Normal-vs-Female |
4.601500E-04 |
| Male-vs-Female |
6.563000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.609840E-04 |
| Normal-vs-Age(41-60Yrs) |
1.681950E-03 |
| Normal-vs-Age(61-80Yrs) |
4.024600E-04 |
| Normal-vs-Age(81-100Yrs) |
7.55180000000522E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.042800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.627010E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.820400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.851600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.026200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.738200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.226170E-02 |
| Normal-vs-Grade 2 |
2.018000E-03 |
| Normal-vs-Grade 3 |
3.381800E-04 |
| Normal-vs-Grade 4 |
2.195400E-04 |
| Grade 1-vs-Grade 2 |
9.766400E-01 |
| Grade 1-vs-Grade 3 |
5.958200E-01 |
| Grade 1-vs-Grade 4 |
5.613200E-01 |
| Grade 2-vs-Grade 3 |
2.292600E-01 |
| Grade 2-vs-Grade 4 |
1.160620E-01 |
| Grade 3-vs-Grade 4 |
7.396400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.14909999999691E-05 |
| Normal-vs-ccB subtype |
3.601400E-03 |
| ccA subtype-vs-ccB subtype |
6.612000E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.636400E-04 |
| Normal-vs-N1 |
1.781930E-04 |
| N0-vs-N1 |
4.413800E-01 |
|
|
